2 Promising New Growth Stocks to Watch in 2023

Some investors turned their backs on growth stocks as economic woes deepened last year. It's important to remember, though, that today's economic troubles and stock market

downturn are temporary. Certain growth stocks may suffer in this sort of context. But they'll be among the first to rebound or extend gains once things improve. That's why

it's never too early to look for smart growth stocks to buy now. I've got two in the healthcare sector that make great candidates to watch this year. One is a medical technology

company that's set to report record earnings. The other is a biotech company with new product revenue and potential new product launches ahead. Let's take a closer look. 1.

InMode InMode (NASDAQ: INMD) makes radiofrequency devices used in various aesthetics and wellness procedures. They're used for skin remodeling, removal of unwanted hair, and

the treatment of weak pelvic floor muscles -- and these are just a few examples. The company benefits from the growth of the global non-invasive aesthetics treatment

market. This market is set to progress at a compound annual growth rate of more than 15% through 2030, according to Grand View Research. That's as patients opt more and more for

non-invasive treatments over surgical aesthetics procedures. InMode already is seeing the results. The company recently offered a sneak peek at its fourth quarter and full

year 2022 earnings -- and they've reached record levels. InMode's non-GAAP earnings per diluted share for the year should be in the range of $2.38 and $2.39. The company also

expects non-GAAP gross margin of at least 83%. And revenue of at least $453.9 million represents a 26% increase from last year.